← FDA DRUG APPROVALS

FDA ANDA · ANDA071215

MEDIPREN

Sponsor: MCNEIL

APPLICATION
ANDA071215
TYPE
ANDA
ORIGINAL APPROVAL
1986-06-26
LATEST ACTION
1989-02-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

MEDIPRENDiscontinued
IBUPROFEN 200MG · TABLET · ORAL

Approval history

1989-02-14Manufacturing (CMC) · Supplement 19AP
1988-09-09Labeling · Supplement 17AP
1988-04-07Manufacturing (CMC) · Supplement 16AP
1988-04-07Manufacturing (CMC) · Supplement 14AP
1988-04-07Manufacturing (CMC) · Supplement 15AP
1987-10-20Manufacturing (CMC) · Supplement 11AP
1987-09-10Manufacturing (CMC) · Supplement 6AP
1987-09-10Manufacturing (CMC) · Supplement 5AP
1986-11-05Manufacturing (CMC) · Supplement 4AP
1986-11-05Manufacturing (CMC) · Supplement 2AP
1986-11-05Manufacturing (CMC) · Supplement 3AP
1986-06-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →